CAS 129453-61-8 Contra el cáncer Fulvestrant Faslodex Fulvestrant acetato polvo con precio de fábrica
Estimados clientes, también hacemos Fulvestrant estándar USP en polvo que es un poco más caro than enterprise standard Fulvestrant.
Fulvestrant/Faslodex Especificación:
| Nombre de fulvestrant | Fulvestrant |
| Alias de fulvestrant | Faslodex |
| Fulvestrant CAS | 129453-61-8 |
| Fulvestrant MF | C32H47F5O3S |
| Fulvestrant MW | 606.77 |
| fulvestrant Apperance | Polvo blanco |
| Ensayo de fulvestrant | 99% |
| NOTA: Fulvestrant is FDA approved for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following anti estrogen therapy. |
Fulvestrant/Faslodex Descripción:
(1) Many breast cancers are stimulated to grow by the female sex hormones oestrogen and progesterone. These breast cancers are called hormone sensitive or hormone receptor positive. Drugs that block the effects of these hormones can slow or stop the growth of the breast cancer cells. Fulvestrante stops oestrogen getting to the cancer cells by blocking oestrogen receptors and reducing the number of receptors the cancer cell has.
(2) Fulvestrant is a highly selective estrogen receptor antagonist. It exerts its action in the body not by targeting the production of estrogen, but by preventing it from exerting activity on the body. It does this bybinding available estrogen receptors in a competitive manner, making them unavailable for circulating estrogens. This mode of action is very similar to Nolvadex and Clomid, although unlike these two agent fulvestrant does not have mixed agonist/antagonist properties.
(3) Fulvestrant is a pure estrogen receptor antagonist. This agent also stands out as the first inject able estrogen antagonist to catch the attention of the athletic and bodybuilding world. Although not widely used here, when applied it may be effective drug for mitigating the side effects of excess estrogen caused by anabolic/androgenic steroid use such as gynecomastia, fat buildup, and increased water retention.
Fulvestrant/ Faslodex Beneficios:
Fulvestrant is administered using intramuscular injections. Faslodex es líquido que se administra una vez al mes como inyección en una biodisponibilidad oral pobre músculo Fulvestranthas, se trata de una solución (líquido) en el buttockto ser administeredvia la inyección intramuscular. Las mujeres generalmente consiguen Faslodex como efectivamente está tratando el cáncer.
La investigación ha demostrado que Faslodex funciona tan bien o mejor que el Arimidex (Nombre químico: anastrozol), un inhibidor de la aromatasa, en frenar o detener el crecimiento de metástasis (cáncer de mama que se ha diseminado a otras partes del cuerpo), el cáncer de mama de hormona-receptor-positive en mujeres posmenopáusicas después de tamoxifeno ha dejado de funcionar.
